Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001104659-25-045516·Bpifrance Participations SA
Schedule 13D ownership disclosure
Innate Pharma SA
Ordinary Shares, nominal value EUR0.05 per share · CUSIP: 45781K105
Event date: 2025-04-25
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Bpifrance Participations S.A.Reported CIK 0001581835
Shares: 6,389,406.00 · Class: 6.9%
- CDC Croissance S.A.
Shares: 930,023.00 · Class: 1.0%
- Caisse des depots et consignationsReported CIK 0001056947
Shares: 7,319,429.00 · Class: 7.9%
- EPIC Bpifrance
Shares: 6,389,406.00 · Class: 6.9%
- Bpifrance S.A.Reported CIK 0001731118
Shares: 6,389,406.00 · Class: 6.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-045516
- Form type
- SCHEDULE 13D/A
- Filer
- Bpifrance Participations SA
- CIK
- CIK 1581835
- Filed
- May 07, 2025
- Reporting period
- Apr 25, 2025
- Description
- Schedule 13D beneficial ownership